4 articles
Swiss start-up Vioneo plans its first fossil-free plastics plant in China, producing 300,000 tonnes of polypropylene and LDPE annually using green methanol by 2030. The move leverages China's feedstoc
GSK plans to acquire Rapt Therapeutics for $2.2 billion while Vioneo relocates a project to China; concurrently, a US snowstorm highlights the essential role of chemical remedies in public safety.
European startup Vioneo shifted its planned green methanol-to-polyolefins plant from Antwerp to China, citing better feedstock access and cost efficiency. Expected to operate by late 2029, the facilit
Vioneo cancels its green polymers facility in Antwerp to build in China instead, citing proximity to green methanol feedstock and better pricing/market access.
ChemBrief